Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krumbholz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 13, 2006
Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutationM Krumbholz, K Koehler, A Huebner
Neurology|October 22, 2008
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosisM Krumbholz, I Meinl, T Kümpfel, et al.
European Journal of Neurology|April 17, 2024
Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndromeE Mulazzani, L Böhm, T Christmann, et al.
Cephalalgia : an International Journal of Headache|July 21, 2009
Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expressionC J Schankin, M Krumbholz, P Sostak, et al.
Bone Marrow Transplantation|July 7, 2015
From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AMLM Krumbholz, J Bradtke, D Stachel, et al.
Neurology|March 21, 2007
Multiple sclerosis: relating MxA transcription to anti-interferon-beta-neutralizing antibodiesL A Hoffmann, M Krumbholz, H Faber, et al.
Plos One|July 28, 2020
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumabC L Kemmerer, V Pernpeintner, C Ruschil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2012
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosisT Kümpfel, L-A Gerdes, T Wacker, et al.
Human Gene Therapy|November 21, 2000
Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vectorI Strobel, M Krumbholz, A Menke, et al.
Neurology|April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximabH L Pellkofer, M Krumbholz, A Berthele, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 13, 2006
Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutationM Krumbholz, K Koehler, A Huebner
Neurology|October 22, 2008
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosisM Krumbholz, I Meinl, T Kümpfel, et al.
European Journal of Neurology|April 17, 2024
Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndromeE Mulazzani, L Böhm, T Christmann, et al.
Cephalalgia : an International Journal of Headache|July 21, 2009
Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expressionC J Schankin, M Krumbholz, P Sostak, et al.
Bone Marrow Transplantation|July 7, 2015
From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AMLM Krumbholz, J Bradtke, D Stachel, et al.
Neurology|March 21, 2007
Multiple sclerosis: relating MxA transcription to anti-interferon-beta-neutralizing antibodiesL A Hoffmann, M Krumbholz, H Faber, et al.
Plos One|July 28, 2020
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumabC L Kemmerer, V Pernpeintner, C Ruschil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2012
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosisT Kümpfel, L-A Gerdes, T Wacker, et al.
Human Gene Therapy|November 21, 2000
Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vectorI Strobel, M Krumbholz, A Menke, et al.
Neurology|April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximabH L Pellkofer, M Krumbholz, A Berthele, et al.
Pageof 2